ZHONGSHENGYAOYE(SZ:002317) Sou Hu Cai Jing·2025-08-01 07:27Group 1 - The core viewpoint of the news highlights the recent performance and financial metrics of Zhongsheng Pharmaceutical, indicating a significant increase in net profit despite a slight decline in total revenue [1] - As of August 1, 2025, Zhongsheng Pharmaceutical's stock price closed at 21.54 yuan, reflecting a 7.49% increase with a trading volume of 1.6361 million hands and a transaction amount of 3.537 billion yuan [1] - The company experienced a net inflow of 449 million yuan in main funds, accounting for 12.69% of the transaction amount, with large orders showing a net inflow of 624 million yuan [1] Group 2 - For the first quarter of 2025, Zhongsheng Pharmaceutical reported total operating revenue of 634 million yuan, a year-on-year decrease of 1.07%, while net profit attributable to shareholders was 82.6118 million yuan, a year-on-year increase of 61.06% [1] - The company has a current ratio of 3.923, a quick ratio of 3.451, and a debt-to-asset ratio of 21.76%, indicating strong liquidity and low leverage [1] - Zhongsheng Pharmaceutical has made investments in 13 companies and has participated in 5,000 bidding projects, showcasing its active engagement in the industry [2]